BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28334900)

  • 1. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
    Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
    Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
    Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
    Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.
    Chen HH; Wang YC; Fann MJ
    Mol Cell Biol; 2006 Apr; 26(7):2736-45. PubMed ID: 16537916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.
    Aversa R; Sorrentino A; Esposito R; Ambrosio MR; Amato A; Zambelli A; Ciccodicola A; D'Apice L; Costa V
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK12 regulates DNA repair genes by suppressing intronic polyadenylation.
    Dubbury SJ; Boutz PL; Sharp PA
    Nature; 2018 Dec; 564(7734):141-145. PubMed ID: 30487607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
    Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
    Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK12: an emerging therapeutic target for cancer.
    Lui GYL; Grandori C; Kemp CJ
    J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
    Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
    Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging roles of CDK12 in tumorigenesis.
    Paculová H; Kohoutek J
    Cell Div; 2017; 12():7. PubMed ID: 29090014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon-level microarray analyses identify alternative splicing programs in breast cancer.
    Lapuk A; Marr H; Jakkula L; Pedro H; Bhattacharya S; Purdom E; Hu Z; Simpson K; Pachter L; Durinck S; Wang N; Parvin B; Fontenay G; Speed T; Garbe J; Stampfer M; Bayandorian H; Dorton S; Clark TA; Schweitzer A; Wyrobek A; Feiler H; Spellman P; Conboy J; Gray JW
    Mol Cancer Res; 2010 Jul; 8(7):961-74. PubMed ID: 20605923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
    Krajewska M; Dries R; Grassetti AV; Dust S; Gao Y; Huang H; Sharma B; Day DS; Kwiatkowski N; Pomaville M; Dodd O; Chipumuro E; Zhang T; Greenleaf AL; Yuan GC; Gray NS; Young RA; Geyer M; Gerber SA; George RE
    Nat Commun; 2019 Apr; 10(1):1757. PubMed ID: 30988284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation.
    Choi SH; Kim S; Jones KA
    Exp Mol Med; 2020 May; 52(5):762-771. PubMed ID: 32451425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex.
    Ekumi KM; Paculova H; Lenasi T; Pospichalova V; Bösken CA; Rybarikova J; Bryja V; Geyer M; Blazek D; Barboric M
    Nucleic Acids Res; 2015 Mar; 43(5):2575-89. PubMed ID: 25712099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
    Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
    Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
    Elife; 2018 Jul; 7():. PubMed ID: 30059005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
    Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
    BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells.
    Han J; Li J; Ho JC; Chia GS; Kato H; Jha S; Yang H; Poellinger L; Lee KL
    Sci Rep; 2017 Jun; 7(1):4108. PubMed ID: 28642487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.
    Naidoo K; Wai PT; Maguire SL; Daley F; Haider S; Kriplani D; Campbell J; Mirza H; Grigoriadis A; Tutt A; Moseley PM; Abdel-Fatah TMA; Chan SYT; Madhusudan S; Rhaka EA; Ellis IO; Lord CJ; Yuan Y; Green AR; Natrajan R
    Mol Cancer Ther; 2018 Jan; 17(1):306-315. PubMed ID: 29133620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.